StockTipsArenaBeta

BUY Mankind Pharma Limited — Kotak Securities

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byKotak SecuritiesHorizon: NA (inferred 1 year)22 Sept 2026via NDTV Profit (Live)

Entry₹2,450Inferred
Target₹3,000
Total upside +22.45%
Stop lossNot given
CMP₹2,6401d ago
Active+7.76%+13.64%upside left 10 mo left
Follow Kotak Securities for new calls(92% target hit, 26 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 7 other Long-term calls on MANKINDSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:28 am IST
28 supporting13 neutral3 opposing
Supports the BUY call (28)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·11 Nov · 3d ago

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

NewsEt-Markets·27 Oct · 3w ago

(opens in new tab)

Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix

NewsCnbc-Tv18·27 Oct · 3w ago

(opens in new tab)

Mankind Pharma jumps 8% on Q2 earnings beat but here's why analysts remain concerned

NewsCnbc-Tv18·27 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (13)

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

NewsNdtv-Profit·27 Oct · 3w ago

(opens in new tab)

Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·26 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (3)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·31 Jul · 4mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Kotak Securities

Every call and its outcome